Issue 8, 2010

3-Iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology?

Abstract

3-Iodothyronamine (T1AM) is an endogenous thyroid hormone derivative with distinct biological effects that are largely opposite those of thyroid hormone. Administration of T1AM to rodents results in rapid and profound reduction in body temperature, heart rate, and metabolism. The structural similarities between thyroxine, T1AM, and monoamine neurotransmitters suggest an intriguing role for T1AM as both a neuromodulator and a hormone-like molecule that may constitute a part of thyroid hormone action. Several recent studies into its molecular mechanisms of action have shown that T1AM can target extracellular receptors such as the trace amine-associated receptors and the α2A adrenergic receptor, modulate the membrane transport of neurotransmitters, and serve as a substrate of specific membrane transport cellular uptake machinery. This review discusses recent T1AM studies, focusing on both the observed in vivo effects of T1AM administration and its actions at the molecular level.

Graphical abstract: 3-Iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology?

Supplementary files

Article information

Article type
Review Article
Submitted
16 Dec 2009
Accepted
08 Feb 2010
First published
04 Mar 2010

Mol. BioSyst., 2010,6, 1338-1344

3-Iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology?

A. G. Ianculescu and T. S. Scanlan, Mol. BioSyst., 2010, 6, 1338 DOI: 10.1039/B926583J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements